GlassScriptPhysician profile
Tapan Jani
NPI 1700049285
$8,934.82
in general payments reported to CMS, 2019-2025
48 companies · $1,568 in 2025
The $1,568 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,167 · 2020: $600 · 2021: $1,156 · 2022: $1,122 · 2023: $1,781 · 2024: $1,540 · 2025: $1,568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,889.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,763.18 | 2019-2025 | Esprit, Pressurewire, Xience Skypoint |
| Abiomed | $1,232.36 | 2019-2025 | Impella |
| Inari Medical, INC. | $846.32 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $445.15 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $423.41 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $409.83 | 2019-2025 | Avvigo Guidance System, Opticross 6, Opticross |
| Shockwave Medical, INC | $395.57 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $352.35 | 2019-2025 | Farxiga |
| Edwards Lifesciences Corporation | $306.14 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $289.24 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $249.47 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $207.46 | 2021-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $186.68 | 2019-2024 | |
| Cardiovascular Systems INC. | $178.25 | 2021-2022 | |
| Medtronic Vascular, INC. | $168.12 | 2019 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tapan Jani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.